2014 Barcelona
Presentations
The speakers below have given their approval to publish their presentation, held during the congress. Please click on the title, to download the presentation in a pdf.
Pasado, presente y futuro de la Hemovigilance
Eduardo Muñiz-diaz (Spain)
Transfusión en España mapa de riesgos
Magdalena Pérez Jiménez (Spain)
La Hemovigilancia en América Latina
Graciel Léon (Venezuela) and Oscar Torres (Argentina)
Aspectos controvertidos en la hemovigilancia de las enfermedades transmisibles
Salvador Oyonarte (Spain)
Los retos pendientes: la enfermera de Hemovigilancia, la formación y capacitación, el uso óptimo
Alba Bosch Llobet (Spain)
A view across the whole transfusion safety chain: Where are the missing and weakest links?
Erica Wood (Australia)
Who are the patients we are transfusing?
Joan R. Grífols
Project Notify: Sharing vigilance experience and knowledge globally
Barbee Whitaker (USA)
Benchmarking blood donor safety practices: a first experience
Gilles Folléa (Belgium) and Pierre Tiberghien (France)
Haemovigilance; The Spanish Haemovigilance System
Miguel Angel Vesga (Spain)
Ten years of Haemovigilance in Spain
Eduardo Muñiz-diaz and Elana Moro (Spain)
Donor complications outside the donation room and their impact on donor return
Núria Nomen (Spain)
Post-donation information: an important element of donor haemovigilance
Teresa Jimenez-Marco (Spain)
The Haemovigilance Nurse in Spain
Nelly Carpio Martinez (Spain)
Safe administration of blood components
Cristina Sanz (Spain)
An overview about HV in Latin American Countries
Oscar Walter Torres
Screening for TTI in Latin America
Jose Ramiro Cruz and Marcia Otani (Colombia)
Side effects of blood donation by apheresis
Hans Vrielink (The Netherlands)
Immediate and Long-Term Complications in Peripheral Blood Stem Cell (PBSC) Donation Procedures
John Miller (USA)
Spanish donor Registry. Follow-Up Data
Javier de la Rubia (Spain)
Does a higher rate of reported transfusion reactions mean a hospital is safer?
Johanna Wiersum-Osselton (The Netherlands)
How comprehensive should the information published about complications of blood donation be?
Jose Manuel Cardenas (Spain)
Donor Selection and Release Criteria for Cellular Therapie Products
John Miller (USA)
Do we think enough about donor welfare? Are more efforts needed to protect donor health?
Peter Tomasulo (USA)
Anxiety and fear; Psychological aspects of blood donation
Anne van Rongen (The Netherlands)
ISTARE: donor vigilance
The Working Group: Constantina Politis (Greece), Philippe Renaudier (France), Clive Richardson (Greece), Pierre Robillard (Canada), Johanna Wiersum (The Netherlands)
How to do a really effective audit. Audits in patient identification and blood tranfusion policy
Georges Andreu (France)
Total Traceability; How is this mandatory instruction being in Europe?
Maria Antónia Escoval and Jorge Condeço (Portugal)
Indications and side effects of plasma and plasma products
Martin Schipperus (The Netherlands)
Education and Training to Improve Transfusion Safety; The Practical, Sensible Steps Taken to Help Achieve a Reduction in Red Blood Cell Usage
Brendan Branigan (Ireland)
Donor Adverse Reactions due to Citrate Infusion during Automated Collections
Hany Kamel (USA)
AABB Validation Study of the CDC National Healthcare Safety Network’s Hemovigilance Module Adverse Events Definitions Protocol
Barbee I Whitaker (USA)
Evaluation of ABO mismatched transfusion in Iran from September 2009 to September 2013
Sima Zolfaghari (Iran)
Layered data reporting allows DonorHART™ to meet a variety of donor vigilance needs: The first annual report of the AABB US Donor Hemovigilance System
Kevin Land (USA)
Donor Vigilance in Blood Transfusion Services, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
Hasan Abbas Zaheer (Pakistan)
Encouraging laboratories to improve practice UK initiatives
Hema Mistry, Bill Chaffe, Hedley Glencross and Paula HB Bolton-Maggs (United Kingdom)
Haemovigilance programme of India (HvPI) – Organizational Structure
Akanksha Bisht (India)